Published in Arthritis Res on September 25, 2002
B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue. Arthritis Res Ther (2007) 1.16
Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus. Ann Rheum Dis (2006) 1.12
Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody. Arthritis Res Ther (2005) 0.97
Incidence of cancer among female patients with systemic lupus erythematosus in Korea. Clin Rheumatol (2009) 0.95
Is the blood B-cell subset profile diagnostic for Sjogren syndrome? Ann Rheum Dis (2008) 0.95
[Sjögren's syndrome. Current aspects from a rheumatological point of view]. Z Rheumatol (2006) 0.82
Antibody-secreting cell specificity in labial salivary glands reflects the clinical presentation and serology in patients with Sjögren's syndrome. Arthritis Rheumatol (2014) 0.81
Possible Mechanisms of Lymphoma Development in Sjögren's Syndrome. Curr Immunol Rev (2013) 0.78
A Potential of sFasL in Preventing Gland Injury in Sjogren's Syndrome. Biomed Res Int (2017) 0.75
Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell (2000) 20.83
Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med (1999) 6.09
A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell (1996) 5.97
Chemokines and cell migration in secondary lymphoid organs. Science (1999) 5.18
Increased risk of lymphoma in sicca syndrome. Ann Intern Med (1978) 4.63
Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. J Clin Invest (2002) 4.14
Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol (2001) 3.87
Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J (1993) 3.85
Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J Exp Med (1999) 3.78
Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis (1996) 3.68
Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J Immunol (1995) 3.31
Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol (2000) 3.05
Identification of functional human splenic memory B cells by expression of CD148 and CD27. J Exp Med (1998) 3.01
Life and death in germinal centers (redux). Immunity (1996) 2.91
BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity (2000) 2.79
HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals. Proc Natl Acad Sci U S A (2001) 2.54
Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells. J Clin Invest (1997) 2.44
B cells expressing CD5 are increased in Sjögren's syndrome. Arthritis Rheum (1988) 2.37
Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc Natl Acad Sci U S A (1996) 2.36
B cell subpopulations separated by CD27 and crucial collaboration of CD27+ B cells and helper T cells in immunoglobulin production. Eur J Immunol (1997) 2.29
Circulating human B cells that express surrogate light chains and edited receptors. Nat Immunol (2000) 2.28
Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. J Clin Invest (2001) 2.26
Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. J Immunol (2000) 2.17
Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus. J Immunol (2001) 2.10
Revising B cell receptors. J Exp Med (2000) 1.96
Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjögren's syndrome. J Clin Invest (1998) 1.92
Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J Immunol (1994) 1.89
Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients. J Immunol (2001) 1.85
Editing disease-associated autoantibodies. Immunity (1997) 1.81
Analysis of the frequency and pattern of somatic mutations within nonproductively rearranged human variable heavy chain genes. J Immunol (1997) 1.80
Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire. J Mol Biol (1999) 1.75
Variable region gene analysis of pathologic human autoantibodies to the related i and I red blood cell antigens. Blood (1991) 1.69
Generation of plasma cells from peripheral blood memory B cells: synergistic effect of interleukin-10 and CD27/CD70 interaction. Blood (1998) 1.66
Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome. Arthritis Rheum (2001) 1.59
Analysis of V(H)-D-J(H) gene transcripts in B cells infiltrating the salivary glands and lymph node tissues of patients with Sjögren's syndrome. Arthritis Rheum (1999) 1.56
Molecular mechanisms and selective influences that shape the kappa gene repertoire of IgM+ B cells. J Clin Invest (1997) 1.52
Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome. J Clin Invest (1998) 1.48
Update in Sjögren syndrome. Curr Opin Rheumatol (2000) 1.47
Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome. Arthritis Rheum (2002) 1.47
Immunoglobulin kappa chain receptor editing in systemic lupus erythematosus. J Clin Invest (1998) 1.45
Control of lymphocyte function through CD27-CD70 interactions. Semin Immunol (1998) 1.33
Repertoire of human antibodies against the polysaccharide capsule of Streptococcus pneumoniae serotype 6B. Infect Immun (1999) 1.32
Receptor editing, immune diversification, and self-tolerance. Immunity (1996) 1.31
Third complementarity-determining region of mutated VH immunoglobulin genes contains shorter V, D, J, P, and N components than non-mutated genes. Immunology (2001) 1.30
IL-10 inhibits apoptotic cell death in human T cells starved of IL-2. Int Immunol (1993) 1.27
Coordinate expansion of 'fetal type' lymphocytes (TCR gamma delta+T and CD5+B) in rheumatoid arthritis and primary Sjögren's syndrome. Clin Exp Immunol (1989) 1.25
Immunoglobulin heavy chain variable region gene replacement As a mechanism for receptor revision in rheumatoid arthritis synovial tissue B lymphocytes. J Exp Med (2000) 1.25
Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma. Clin Immunol (1999) 1.24
Pairing of variable heavy and variable kappa chains in individual naive and memory B cells. J Immunol (1998) 1.20
Salivary gland mucosa-associated lymphoid tissue lymphoma immunoglobulin V(H) genes show frequent use of V1-69 with distinctive CDR3 features. Blood (2000) 1.17
Ongoing Ig gene hypermutation in salivary gland mucosa-associated lymphoid tissue-type lymphomas. Blood (1997) 1.16
Human lupus anti-DNA autoantibodies undergo essentially primary V kappa gene rearrangements. EMBO J (1994) 1.10
Expression and release of CD27 in human B-cell malignancies. Blood (1993) 1.10
Molecular mechanisms and selection influence the generation of the human V lambda J lambda repertoire. J Immunol (1999) 1.10
Ig lambda and heavy chain gene usage in early untreated systemic lupus erythematosus suggests intensive B cell stimulation. J Immunol (1999) 1.09
Clonal salivary gland infiltrates associated with myoepithelial sialadenitis (Sjögren's syndrome) begin as nonmalignant antigen-selected expansions. Blood (1998) 1.09
Immunoglobulin variable-region gene usage in systemic autoimmune diseases. Arthritis Rheum (2001) 1.06
CD4 cytotoxic and dendritic cells in the immunopathologic lesion of Sjögren's syndrome. Clin Exp Immunol (1999) 1.06
Autoimmunity and lymphoma: tribulations of B cells. Nat Immunol (2001) 1.03
CD27/CD70 interaction augments IgE secretion by promoting the differentiation of memory B cells into plasma cells. J Immunol (1998) 1.01
Enhanced mutational activity of Vkappa gene rearrangements in systemic lupus erythematosus. Clin Immunol (1999) 0.99
Salivary gland lymphomas in patients with Sjögren's syndrome may frequently develop from rheumatoid factor B cells. Arthritis Rheum (2000) 0.99
Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjögren's syndrome. Arthritis Rheum (1997) 0.97
Use of muscarinic agonists in the treatment of Sjögren's syndrome. Clin Immunol (2001) 0.97
Molecular characterization of a major autoantibody-associated cross-reactive idiotype in Sjogren's syndrome. J Immunol (1989) 0.95
The different process of class switching and somatic hypermutation; a novel analysis by CD27(-) naive B cells. Blood (2002) 0.95
The repertoire of human antibody to the Haemophilus influenzae type b capsular polysaccharide. Int Rev Immunol (1992) 0.94
Impaired up-regulation of CD86 in B cells of "type A" common variable immunodeficiency patients. Eur J Immunol (2000) 0.92
RAG1 and RAG2 expression by B cell subsets from human tonsil and peripheral blood. J Immunol (2001) 0.91
Chemokines and cell trafficking in Sjögren's syndrome. Scand J Immunol (2001) 0.90
Sjögren's syndrome revisited: autoimmune epithelitis. Br J Rheumatol (1996) 0.89
Lymphoid infiltrates of the salivary glands: pathology, biology and clinical significance. Curr Opin Oncol (1996) 0.88
Increased frequency of cells secreting interleukin-6 and interleukin-10 in peripheral blood of patients with primary Sjögren's syndrome. Scand J Immunol (1999) 0.88
Comparable impact of mutational and selective influences in shaping the expressed repertoire of peripheral IgM+/CD5- and IgM+/CD5+ B cells. Eur J Immunol (1998) 0.88
From human autoantibodies to the fetal antibody repertoire to B cell malignancy: it's a small world after all. Int Rev Immunol (1990) 0.88
'Fetal-type' B and T lymphocytes in rheumatoid arthritis and primary Sjögren's syndrome. J Autoimmun (1989) 0.87
Expression of recombination-activating genes and terminal deoxynucleotidyl transferase and secondary rearrangement of immunoglobulin kappa light chains in rheumatoid arthritis synovial tissue. Arthritis Rheum (2001) 0.87
Chronic lymphocytic leukemia preceded by cold agglutinin disease: intraclonal immunoglobulin light-chain diversity in V(H)4-34 expressing single leukemic B cells. Blood (2002) 0.85
Direct B/B-cell interactions in immunoglobulin synthesis. Clin Exp Immunol (2001) 0.85
Perturbations in the impact of mutational activity on Vlambda genes in systemic lupus erythematosus. Arthritis Res (2001) 0.83
The V lambda J lambda repertoire in human fetal spleen: evidence for positive selection and extensive receptor editing. J Immunol (2000) 0.83
Co-existent anti-La antibodies and rheumatoid factors bear distinct idiotypic markers. Scand J Rheumatol Suppl (1988) 0.81
Comparative characteristics of mu chain and alpha chain transcripts expressed by individual tonsil plasma cells. Mol Immunol (2001) 0.81
Expression of rheumatoid factor associated cross-reactive idiotopes by glandular B cells in Sjögren's syndrome. Clin Exp Immunol (1991) 0.81
Immunoglobulin Vkappa light chain gene analysis in patients with Sjögren's syndrome. Arthritis Rheum (2001) 0.81
Light chain variable (VL) sequences of rheumatoid factors (RF) in patients with primary Sjögren's syndrome (pSS): moderate contribution of somatic hypermutation. Scand J Immunol (1999) 0.80
Immunoglobulin Vlambda light chain gene usage in patients with Sjögren's syndrome. Arthritis Rheum (2001) 0.80
A complete map of the human immunoglobulin VH locus. Ann N Y Acad Sci (1995) 0.80
Analysis of immunoglobulin light chain rearrangements in the salivary gland and blood of a patient with Sjögren's syndrome. Arthritis Res (2002) 0.79
Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment. In Vivo (1995) 0.78
B cells expressing CD5 in minor labial salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum (1990) 0.78
Monotypic plasma cells in labial salivary glands of patients with Sjögren's syndrome: prognosticator for systemic lymphoproliferative disease. J Clin Pathol (1993) 0.77
Levels of CD5+ B cells are not increased in probands or relatives in a family study of primary Sjögren's syndrome. Autoimmunity (1992) 0.75
TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. Blood (2006) 4.63
Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol (2004) 4.43
IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J Immunol (2005) 4.04
Identification and characterization of circulating human transitional B cells. Blood (2005) 3.62
Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol (2007) 3.49
Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol (2007) 3.22
Characterization of the human Ig heavy chain antigen binding complementarity determining region 3 using a newly developed software algorithm, JOINSOLVER. J Immunol (2004) 2.62
Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration. J Immunol (2007) 2.56
Patterns of microRNA expression characterize stages of human B-cell differentiation. Blood (2009) 2.46
Magnetic resonance imaging in the evaluation of bone damage in rheumatoid arthritis: a more precise image or just a more expensive one? Arthritis Rheum (2003) 2.37
Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum (2003) 2.32
Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs. Blood (2010) 2.15
The role of IL-21 in regulating B-cell function in health and disease. Immunol Rev (2008) 2.09
Stepwise differentiation of CD4 memory T cells defined by expression of CCR7 and CD27. J Immunol (2005) 2.01
Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein. J Exp Med (2005) 2.00
Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95. Arthritis Rheum (2008) 2.00
Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum (2006) 1.87
Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study. Arthritis Rheum (2010) 1.86
Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study. Arthritis Rheum (2002) 1.81
Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae). Phytochemistry (2007) 1.74
Revisiting the ancient concept of botanical therapeutics. Nat Chem Biol (2007) 1.71
Comparison of antibody repertoires produced by HIV-1 infection, other chronic and acute infections, and systemic autoimmune disease. PLoS One (2011) 1.68
The IL-4 receptor alpha-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+ regulatory T cells from CD25-CD4+ precursors. J Immunol (2005) 1.66
Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sjögren's syndrome. Arthritis Rheum (2005) 1.65
Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions. J Clin Invest (2003) 1.63
IL-21 and BAFF/BLyS synergize in stimulating plasma cell differentiation from a unique population of human splenic memory B cells. J Immunol (2007) 1.62
Identification and characterization of a human CD5+ pre-naive B cell population. J Immunol (2009) 1.59
A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib. Blood (2003) 1.54
Mechanisms of B cell autoimmunity in SLE. Arthritis Res Ther (2011) 1.53
Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial. Ann Intern Med (2009) 1.53
Effect of a culturally sensitive cholesterol lowering diet program on lipid and lipoproteins, body weight, nutrient intakes, and quality of life in patients with systemic lupus erythematosus. J Rheumatol (2002) 1.49
Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome. Arthritis Rheum (2002) 1.47
The role of the T cell in autoimmune inflammation. Arthritis Res Ther (2005) 1.46
Immunopathogenesis of primary Sjögren's syndrome: implications for disease management and therapy. Curr Opin Rheumatol (2005) 1.46
CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases. Nat Clin Pract Rheumatol (2007) 1.42
Abnormalities of B cell subsets in patients with systemic lupus erythematosus. J Immunol Methods (2010) 1.30
Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor. Arthritis Res Ther (2009) 1.27
Anti-inflammatory and immunosuppressive compounds from Tripterygium wilfordii. Phytochemistry (2007) 1.26
Biomarkers in systemic lupus erythematosus. I. General overview of biomarkers and their applicability. Arthritis Rheum (2004) 1.25
SLE peripheral blood B cell, T cell and myeloid cell transcriptomes display unique profiles and each subset contributes to the interferon signature. PLoS One (2013) 1.25
TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-{kappa}B activation. J Biol Chem (2004) 1.24
The low affinity IgE receptor (CD23) is cleaved by the metalloproteinase ADAM10. J Biol Chem (2007) 1.21
Secondary immunization generates clonally related antigen-specific plasma cells and memory B cells. J Immunol (2010) 1.20
Biomarkers in systemic lupus erythematosus: II. Markers of disease activity. Arthritis Rheum (2004) 1.20
Dendritic cells, chemokine receptors and autoimmune inflammatory diseases. Immunol Cell Biol (2002) 1.19
New concepts in the pathogenesis of Sjögren syndrome: many questions, fewer answers. Curr Opin Rheumatol (2003) 1.19
Chemokine receptor expression and functional effects of chemokines on B cells: implication in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther (2009) 1.19
B-cell lymphoproliferation in chronic inflammatory rheumatic diseases. Nat Clin Pract Rheumatol (2007) 1.18
Association of the IL4R single-nucleotide polymorphism I50V with rapidly erosive rheumatoid arthritis. Arthritis Rheum (2006) 1.17
B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue. Arthritis Res Ther (2007) 1.16
B cell abnormalities in systemic lupus erythematosus. Arthritis Res Ther (2003) 1.15
Receptor revision and atypical mutational characteristics in clonally expanded B cells from the cerebrospinal fluid of recently diagnosed multiple sclerosis patients. J Neuroimmunol (2005) 1.14
B cells in autoimmunity. Arthritis Res Ther (2009) 1.13
T cell-dependent survival of CD20+ and CD20- plasma cells in human secondary lymphoid tissue. Blood (2007) 1.11
Analysis of somatic hypermutation in X-linked hyper-IgM syndrome shows specific deficiencies in mutational targeting. Blood (2008) 1.11
Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout. Arthritis Res Ther (2014) 1.10
GATA-3 in human T cell helper type 2 development. J Exp Med (2004) 1.09
Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene. Blood (2002) 1.09
Abnormalities in peripheral B cell memory of patients with primary Sjögren's syndrome. Arthritis Rheum (2004) 1.08
Role of the spleen in peripheral memory B-cell homeostasis in patients with autoimmune thrombocytopenia purpura. Clin Immunol (2008) 1.07
Measurement of two caspase activities simultaneously in living cells by a novel dual FRET fluorescent indicator probe. Cytometry A (2006) 1.07
Criteria for early rheumatoid arthritis: from Bayes' law revisited to new thoughts on pathogenesis. Arthritis Rheum (2002) 1.07
Abnormal differentiation of memory T cells in systemic lupus erythematosus. Arthritis Rheum (2006) 1.06
Are autoantibodies the targets of B-cell-directed therapy? Nat Rev Rheumatol (2011) 1.05
Developmental changes in the human heavy chain CDR3. J Immunol (2005) 1.04
A flow cytometric method to detect protein-protein interaction in living cells by directly visualizing donor fluorophore quenching during CFP-->YFP fluorescence resonance energy transfer (FRET). Cytometry A (2003) 1.03
Flow cytometric measurement of fluorescence (Förster) resonance energy transfer from cyan fluorescent protein to yellow fluorescent protein using single-laser excitation at 458 nm. Cytometry A (2003) 1.02
The role of polymerase eta in somatic hypermutation determined by analysis of mutations in a patient with xeroderma pigmentosum variant. J Immunol (2002) 1.01
Regulatory T cells in rheumatoid arthritis. Arthritis Res Ther (2005) 1.00
B-cell targeting: a novel approach to immune intervention today and tomorrow. Expert Opin Biol Ther (2007) 0.98
CD154-CD40 interactions mediate differentiation to plasma cells in healthy individuals and persons with systemic lupus erythematosus. Arthritis Rheum (2002) 0.98
Generation and regulation of human Th1-biased immune responses in vivo: a critical role for IL-4 and IL-10. J Immunol (2004) 0.98
Biomarkers in systemic lupus erythematosus. Curr Rheumatol Rep (2004) 0.97
CD4+ T cells recognizing a single self-peptide expressed by APCs induce spontaneous autoimmune arthritis. J Immunol (2008) 0.96
Why do B cells mutate their immunoglobulin receptors? Trends Immunol (2006) 0.95
New concepts in the treatment of rheumatoid arthritis. Annu Rev Med (2001) 0.94
Splenic proliferative lymphoid nodules distinct from germinal centers are sites of autoantigen stimulation in immune thrombocytopenia. Blood (2012) 0.93
miR-142-3p is involved in CD25+ CD4 T cell proliferation by targeting the expression of glycoprotein A repetitions predominant. J Immunol (2013) 0.92
Flow cytometric assessment of the signaling status of human B lymphocytes from normal and autoimmune individuals. Arthritis Res Ther (2004) 0.91
Sensitivity of femoral orientation estimates to condylar surface and MR image plane location. J Magn Reson Imaging (2004) 0.91
Determination of tumor necrosis factor receptor-associated factor trimerization in living cells by CFP->YFP->mRFP FRET detected by flow cytometry. Nucleic Acids Res (2005) 0.90
Why do we not have a cure for rheumatoid arthritis? Arthritis Res (2002) 0.90
Patients with chronic granulomatous disease have a reduced peripheral blood memory B cell compartment. J Immunol (2006) 0.90
Effective therapy for nephritis in (NZB x NZW)F1 mice with triptolide and tripdiolide, the principal active components of the Chinese herbal remedy Tripterygium wilfordii Hook F. Arthritis Rheum (2008) 0.89
Specific in vivo deletion of B-cell subpopulations expressing human immunoglobulins by the B-cell superantigen protein L. Infect Immun (2004) 0.89
Inflammation, immune reactivity, and angiogenesis in a severe combined immunodeficiency model of rheumatoid arthritis. Am J Pathol (2002) 0.88
The p38 mitogen-activated protein kinase regulates effector functions of primary human CD4 T cells. Eur J Immunol (2005) 0.88
B cells: depletion or functional modulation in rheumatic diseases. Curr Opin Rheumatol (2014) 0.88
Expression of recombination activating genes 1 and 2 in peripheral B cells of patients with systemic lupus erythematosus. Arthritis Rheum (2002) 0.87
Staphylococcal protein a deletes B-1a and marginal zone B lymphocytes expressing human immunoglobulins: an immune evasion mechanism. J Immunol (2005) 0.87
Sustained secretion of immunoglobulin by long-lived human tonsil plasma cells. Am J Pathol (2007) 0.87
Therapeutic impact of the ethyl acetate extract of Tripterygium wilfordii Hook F on nephritis in NZB/W F1 mice. Arthritis Res Ther (2006) 0.86
Immunglobulin repertoire analysis provides new insights into the immunopathogenesis of Sjögren's syndrome. Autoimmun Rev (2002) 0.86
Molecular characterization of circulating plasma cells in patients with active systemic lupus erythematosus. PLoS One (2012) 0.86
TRAF6 regulates cell fate decisions by inducing caspase 8-dependent apoptosis and the activation of NF-kappaB. J Biol Chem (2006) 0.85
Aberrant CD200/CD200R1 expression and function in systemic lupus erythematosus contributes to abnormal T-cell responsiveness and dendritic cell activity. Arthritis Res Ther (2012) 0.84
Tissue distribution and dependence of responsiveness of human antigen-specific memory B cells. J Immunol (2014) 0.83
Increased frequency of a unique spleen tyrosine kinase bright memory B cell population in systemic lupus erythematosus. Arthritis Rheumatol (2014) 0.82
The NF-kappaB canonical pathway is involved in the control of the exonucleolytic processing of coding ends during V(D)J recombination. J Immunol (2008) 0.82